Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Frontiers in Pharmacology|October 22, 2019
Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant <i>Pseudomonas aeruginosa</i>Yu-Wei Lin, Mei-Ling Han, Jinxin Zhao, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infectionsSujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activityJustin R Lenhard, Visanu Thamlikitkul, Fernanda P Silveira, et al.
The AAPS Journal|March 19, 2020
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer PatientsSpinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection modelBrian VanScoy, Rodrigo E Mendes, Anthony M Nicasio, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2012
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysisAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection ModelAnthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
The American Journal on Addictions|December 7, 2007
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavirNiamh Higgins, Barry S Zingman, Judianne Slish, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimensAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniaeYu-Wei Lin, Nusaibah Abdul Rahim, Jinxin Zhao, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Frontiers in Pharmacology|October 22, 2019
Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant <i>Pseudomonas aeruginosa</i>Yu-Wei Lin, Mei-Ling Han, Jinxin Zhao, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infectionsSujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activityJustin R Lenhard, Visanu Thamlikitkul, Fernanda P Silveira, et al.
The AAPS Journal|March 19, 2020
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer PatientsSpinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection modelBrian VanScoy, Rodrigo E Mendes, Anthony M Nicasio, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2012
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysisAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection ModelAnthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
The American Journal on Addictions|December 7, 2007
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavirNiamh Higgins, Barry S Zingman, Judianne Slish, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimensAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniaeYu-Wei Lin, Nusaibah Abdul Rahim, Jinxin Zhao, et al.
Pageof 18